Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy.

Autor:	Li Fu1, Wasiak, Sylwia1, Tsujikawa, Laura M.1, Rakai, Brooke D.1, Stotz, Stephanie C.1, Wong, Norman C. W.1, Johansson, Jan O., Sweeney, Michael, Mohan, Connie M.2, Khan, Aneal2,3, Kulikowski, Ewelina1 Ewelina@resverlogix.com
Zdroj:	Pharmacology Research & Perspectives. Jun2022, Vol. 10 Issue 3, p1-14. 14p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu